Menu

Skip to content
  • Home
  • People
  • Research
    • Influenza Virus
    • Oncolytic Viruses
    • Type I IFN
    • Viral IFN Antagonists
  • Publications
  • Contact

Garcia-Sastre Laboratory 

icahn.mssm.edu   /   Inside Mount Sinai Blog

Menu

Skip to content
  • Home
  • People
  • Research
    • Influenza Virus
    • Oncolytic Viruses
    • Type I IFN
    • Viral IFN Antagonists
  • Publications
  • Contact

Rebecca Pearl

Associate Researcher
rebecca.pearl@mssm.edu

 

 

 

 

 

 

 

RSS Recent Publications

  • 2024 Update of the RECOVER-Adult Long COVID Research Index December 18, 2024 Linda N Geng
  • TRIM65 regulates innate immune signaling by enhancing K6-linked ubiquitination of IRF3 and its chromatin recruitment November 24, 2024 Danae Fonseca
  • Outcome of SARS-CoV-2 reinfection depends on genetic background in female mice November 23, 2024 Gagandeep Singh
  • Extracellular vesicles containing SARS-CoV-2 proteins are associated with multi-organ dysfunction and worse outcomes in patients with severe COVID-19 November 19, 2024 Diego de Miguel-Perez
  • Recombination across distant coronavirid species and genera is a rare event with distinct genomic features November 19, 2024 Juan Patiño-Galindo
  • Avian influenza A (H5N1) virus in dairy cattle: origin, evolution, and cross-species transmission November 13, 2024 Ahmed Mostafa
  • Phase II study on the safety and immunogenicity of single-dose intramuscular or intranasal administration of the AVX/COVID-12 "Patria" recombinant Newcastle disease virus vaccine as a heterologous booster against COVID-19 in Mexico November 11, 2024 Constantino López-Macías
  • Enhanced mucosal SARS-CoV-2 immunity after heterologous intramuscular mRNA prime/intranasal protein boost vaccination with a combination adjuvant November 3, 2024 Gabriel Laghlali
  • Identification and Targeting of Regulators of SARS-CoV-2-Host Interactions in the Airway Epithelium October 28, 2024 Brooke Dirvin
  • Comparative Analysis of 2022 Outbreak MPXV and Previous Clade II MPXV October 28, 2024 Joseph Patrick McGrail
  • Adaptive multi-epitope targeting and avidity-enhanced nanobody platform for ultrapotent, durable antiviral therapy October 24, 2024 Yufei Xiang
  • Measurement of circulating viral antigens post-SARS-CoV-2 infection in a multicohort study October 10, 2024 Zoe Swank
  • Cellular NS1-BP protein interacts with the mRNA export receptor NXF1 to mediate nuclear export of influenza virus M mRNAs October 9, 2024 Ke Zhang
  • Inhibition of SARS-CoV-2 growth in the lungs of mice by a peptide-conjugated morpholino oligomer targeting viral RNA October 8, 2024 Alexandra Sakai
  • Sequential immunization with chimeric hemagglutinin ΔNS1 attenuated influenza vaccines induces broad humoral and cellular immunity September 19, 2024 Raveen Rathnasinghe

Upcoming Events

Click here to view a calendar with upcoming events.

Careers | Contact Us | Privacy | Legal
800-MD-SINAI
© Icahn School of Medicine at Mount Sinai